GB1498913A - Magnesium-containing pharmaceutical compositions - Google Patents

Magnesium-containing pharmaceutical compositions

Info

Publication number
GB1498913A
GB1498913A GB6422/76A GB642276A GB1498913A GB 1498913 A GB1498913 A GB 1498913A GB 6422/76 A GB6422/76 A GB 6422/76A GB 642276 A GB642276 A GB 642276A GB 1498913 A GB1498913 A GB 1498913A
Authority
GB
United Kingdom
Prior art keywords
magnesium
compositions
strontium
chloride
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB6422/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VERLA PHARM
Original Assignee
VERLA PHARM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VERLA PHARM filed Critical VERLA PHARM
Publication of GB1498913A publication Critical patent/GB1498913A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GB6422/76A 1975-02-20 1976-02-18 Magnesium-containing pharmaceutical compositions Expired GB1498913A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752507354 DE2507354A1 (de) 1975-02-20 1975-02-20 Pharmazeutische zubereitung

Publications (1)

Publication Number Publication Date
GB1498913A true GB1498913A (en) 1978-01-25

Family

ID=5939402

Family Applications (1)

Application Number Title Priority Date Filing Date
GB6422/76A Expired GB1498913A (en) 1975-02-20 1976-02-18 Magnesium-containing pharmaceutical compositions

Country Status (4)

Country Link
US (1) US4041154A (US07494231-20090224-C00006.png)
DE (1) DE2507354A1 (US07494231-20090224-C00006.png)
FR (1) FR2301244A1 (US07494231-20090224-C00006.png)
GB (1) GB1498913A (US07494231-20090224-C00006.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2720288C2 (de) * 1977-05-05 1984-02-16 Verlapharm v. Ehrlich AG, Emmenbrücke Verwendung von Magnesiumsalzen zur Herstellung von Zubereitungen zur Behandlung von Nutztieren
US4196196A (en) * 1978-06-19 1980-04-01 Tiholiz Ivan C Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states
EP0174957A4 (en) * 1984-03-01 1987-11-09 Vernon Erk METHOD FOR THE TREATMENT OF MEMORY DISORDERS IN ELDERLY PEOPLE.
WO1985003867A1 (en) * 1984-03-01 1985-09-12 Vernon Erk Method of changing the rate of oxidation of amines in vertebrates and other organisms
FR2673512B1 (fr) * 1991-03-05 1993-08-20 Inst Rech Biolog Sa Nouvelles compositions dietetiques a base de lipides complexes phosphores et leur utilisation dans les troubles du sommeil.
DE19809600C1 (de) * 1998-03-03 1999-10-21 Heberlein Fasertech Ag Garnbehandlungseinrichtung
DE19830310A1 (de) * 1998-07-07 2000-01-13 Riedel De Haen Gmbh Verfahren zur Abreicherung des Bromidgehaltes aus einer wäßrigen Bromid enthaltenden Lösung unter Verwendung von Wasserstoffperoxid
US6579905B1 (en) 2001-11-19 2003-06-17 Mcmains Michael B. Method for the prevention or treatment of hypomagnesemia in pediatric patients and in patients with G-tubes or NG-tubes
US11369630B1 (en) * 2018-10-31 2022-06-28 Flex-It Mg Llc Formulations of magnesium chloride to treat muscle spasm, strain and sprain
JP7407462B2 (ja) * 2019-03-26 2024-01-04 ウィンサンター・インコーポレイテッド 末梢神経障害の処置のための局所製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836668A (en) * 1960-12-27 1974-09-17 Ferrer Labor Therapeutic composition and method of treating patients therewith
GB1141633A (en) * 1965-02-27 1969-01-29 Serono Ist Farm Improvements in or relating to aspartic acid derivatives
US3674882A (en) * 1968-05-17 1972-07-04 Sandoz Ag Dichloro trifluoromethyl phenyl lithium
US3778505A (en) * 1970-12-01 1973-12-11 Rech Etudes Therapeutiques Soc Lithium salt based pharmaceutical composition and methods of use

Also Published As

Publication number Publication date
FR2301244B1 (US07494231-20090224-C00006.png) 1979-07-20
US4041154A (en) 1977-08-09
DE2507354A1 (de) 1976-09-09
FR2301244A1 (fr) 1976-09-17

Similar Documents

Publication Publication Date Title
GB2137616B (en) Novel compounds
GB1498913A (en) Magnesium-containing pharmaceutical compositions
AU1116088A (en) Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
KR930701196A (ko) 신규한 치료
US3857939A (en) Chewable sodium-free vitamin c tablets
ES8502440A1 (es) Procedimiento para preparar acepinoindoles.
DE2965732D1 (en) Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition
IL70913A0 (en) Complexes of prostaglandins,their preparation and pharmaceutical compositions containing them
US4443476A (en) Treatment of adult respiratory distress syndrome
ES8800208A1 (es) Un procedimiento para la preparacion de 1-metil-4,5-dihidroorotil-histidil-prolinamida
DE3380294D1 (en) Pharmaceutical compositions in oral dosage form
NO163133C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv 5r, 6s, 8r-6-(1-hydroxyethyl)-2-(2-carbamoyloxy-ethylthio)-penem-3-carboxylsyre.
GB1097074A (en) Guanidine derivatives and compositions containing the same
ES2009930A6 (es) Mejoras en la patente de invencion 537.819 por procedimiento para anchoar.
ES8502867A1 (es) Procedimiento para preparar 2-alquiltio-1-amino-alquil-2-pirrolin-3-carbonitrilos
PT84885A (en) Process for the preparation of ion mixed salts of monofluorinephosphate with aminoacids and sodium chloride and of pharmaceutical compositions containing them
GB1333010A (en) Pharmaceutical compositions containing lithium
GB1271567A (en) Production of anticapsin
SU577715A1 (ru) Инсектицидный гранулированный или порошкообразный препарат
GB822422A (en) Tetracycline antibiotic compositions
JPS57179115A (en) Medicinal composition containing cytidine phosphocholine or salt for oral administration

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940218